NCS Healthcare, Inc., a financially distressed company with a dual-class capital structure, negotiated a strategic transaction with Genesis Health Ventures after receiving and considering expressions of interest from Omnicare, Inc. and others. Two NCS co-founders and directors, Kevin Shaw and Jon Outcalt, held super-voting Class B shares that together constituted a majority of NCS's voting power. NCS's board ultimately approved a merger agreement with Genesis that contained a no-shop clause restricting NCS from soliciting or negotiating with other bidders, a force-the-vote provision under DGCL § 251(c) requiring submission of the merger to a stockholder vote even if the board later changed its recommendation, and no termination right permitting NCS to accept a superior proposal (i.e., no fiduciary out to terminate). Concurrently, Shaw and Outcalt executed voting agreements committing their majority voting power to vote in favor of the Genesis merger and granting Genesis irrevocable proxies. Shortly thereafter, Omnicare made a superior all-cash offer. The NCS board determined Omnicare's proposal was superior and changed its recommendation but found itself unable to terminate the Genesis agreement or avoid submitting the Genesis merger to a vote that Genesis would win regardless, due to the voting agreements. Litigation ensued. The Court of Chancery denied injunctive relief, but the Delaware Supreme Court accepted an interlocutory appeal.
Whether the combination of a force-the-vote provision, a no-shop that lacked a termination fiduciary out, and voting agreements locking up a majority of the vote was an impermissible defensive measure under Unocal because it was coercive or preclusive and improperly constrained the directors' continuing fiduciary duties.
Under Unocal's enhanced scrutiny, when directors adopt defensive measures in response to a perceived threat, they must show (1) reasonable grounds for believing a threat to corporate policy and effectiveness existed, and (2) that the defensive response was neither coercive nor preclusive and was reasonable in relation to the threat. Directors cannot contractually disable themselves from exercising their continuing fiduciary duties; deal-protection measures that effectively render stockholder approval a foregone conclusion or prevent the board from responding to superior proposals fall outside a range of reasonableness and are invalid. See Unocal Corp. v. Mesa Petroleum Co.; Unitrin, Inc. v. American Gen. Corp.; Paramount Commc'ns v. QVC Network.
The Delaware Supreme Court reversed and enjoined enforcement of the deal protections. The combination of the force-the-vote provision, the no-shop without a termination fiduciary out, and the voting agreements that locked up a majority of the voting power made approval of the Genesis merger a fait accompli. Those measures were both preclusive and coercive, and therefore unreasonable under Unocal.
The Court applied Unocal because the board adopted the measures in a defensive posture to secure a favored transaction and deter interlopers. On step one, the Court acknowledged that preserving the Genesis deal could be a legitimate concern, given NCS's financial distress. On step two, however, the Court found the measures disproportionate. The voting agreements by the Class B holders ensured a majority in favor of the Genesis merger. Coupled with DGCL § 251(c)'s force-the-vote clause—which compelled a stockholder vote even after the board changed its recommendation—and the absence of any termination right to accept a superior bid, the package made any subsequent superior offer futile. That is the essence of preclusion: the deal protections rendered the success of a rival bid either mathematically impossible or realistically unattainable. It was also coercive because stockholders were forced to vote on the Genesis deal despite a non-recommendation, with no meaningful alternative path available. The Court emphasized that directors possess ongoing fiduciary duties that cannot be bargained away by contract. Although DGCL § 251(c) permits force-the-vote provisions, and § 218 allows stockholder voting agreements, those statutory permissions do not license the board to create an unbreakable lock-up that disables it from considering or accepting a superior proposal. In the Court's view, a conventional fiduciary out—one that allows termination of the existing agreement upon payment of a reasonable termination fee to accept a superior proposal—preserves necessary flexibility. Here, the absence of a termination fiduciary out, in light of the majority voting lock-up, exceeded the range of reasonableness. The Court rejected arguments that stockholder freedom to contract insulated the voting agreements. While stockholders generally may bind their votes, these agreements were part of a defensive package orchestrated and approved by the board in response to a threat; thus, they were subject to Unocal review in context. The Court also observed that the statutory authorization of force-the-vote did not absolve fiduciary constraints. A dissent would have upheld the structure, reasoning that the measures were permissible under the DGCL and that the market remained free to bid, but the majority concluded the measures made any superior transaction illusory.
Omnicare is a leading authority that directors cannot deploy deal protections to predetermine outcomes. It effectively requires, in practice, a termination fiduciary out in public company mergers, and it cautions against majority lock-ups through voting agreements when combined with a force-the-vote. The decision sharpened the application of Unocal and Unitrin to deal protections, defining preclusive and coercive effects in concrete M&A settings. For law students, it illustrates the tension between contractual certainty and fiduciary flexibility, and it remains a drafting roadmap: include fiduciary outs, calibrate termination fees, avoid vote outcomes that become a fait accompli, and ensure boards retain meaningful latitude to respond to superior proposals.
Omnicare v. NCS Healthcare stands for the proposition that directors cannot ensure deal certainty by sacrificing fiduciary flexibility. Even where statutes permit certain contractual mechanisms, their use must pass Unocal's enhanced scrutiny. When defensive measures, taken together, effectively lock up a transaction and prevent response to superior bids, they are invalid.